GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Other Current Payables

HLB Science (XKRX:343090) Other Current Payables : ₩356.95 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Other Current Payables?

HLB Science's Other Current Payables for the quarter that ended in Dec. 2023 was ₩356.95 Mil.

HLB Science's quarterly Other Current Payables increased from . 20 (₩0.00 Mil) to Dec. 2022 (₩1,138.86 Mil) but then declined from Dec. 2022 (₩1,138.86 Mil) to Dec. 2023 (₩356.95 Mil).

HLB Science's annual Other Current Payables increased from . 20 (₩0.00 Mil) to Dec. 2022 (₩1,138.86 Mil) but then declined from Dec. 2022 (₩1,138.86 Mil) to Dec. 2023 (₩356.95 Mil).


HLB Science Other Current Payables Historical Data

The historical data trend for HLB Science's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Other Current Payables Chart

HLB Science Annual Data
Trend Dec22 Dec23
Other Current Payables
1,138.86 356.95

HLB Science Semi-Annual Data
Dec22 Dec23
Other Current Payables 1,138.86 356.95

HLB Science Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


HLB Science Other Current Payables Related Terms

Thank you for viewing the detailed overview of HLB Science's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science Headlines

No Headlines